CTOs on the Move

Create Orthotics and Prosthetics

www.createoandp.com

 
Create O&P offers intuitive 3D printing and digital solutions to orthotists and prosthetists worldwide. We provide the tools, training, and support for O&P practices to incorporate digital workflows into their current patient care. Modernizing your practice creates stress. We create solutions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MedicSight

MedicSight is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Quality Home Care Providers

Quality Home Care Providers is a Leonia, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medela

Through advancing research, observing natural behavior, and listening to our customers, Medela turns science into care while nurturing health for generations. Medela supports millions of moms, babies, patients, and healthcare professionals in more than 100 countries all over the world. As the healthcare choice for more than 6 million hospitals and homes across the globe, Medela provides the leading research-based breast milk feeding and baby products, healthcare solutions for hospitals, and clinical education.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.

Simbionix USA Corporation

Simbionix USA Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.